^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
GENE:

BNIP5 (BCL2 Interacting Protein 5)

i
Other names: BNIP5, BCL2 Interacting Protein 5, C6orf222, DKFZp779B1540, Protein BNIP5, Chromosome 6 Open Reading Frame 222, Uncharacterized Protein C6orf222
Associations
Trials
over2years
Predictive value of DNA methylation in the efficacy of chemotherapy for gastric cancer. (PubMed, Front Oncol)
The Kyoto Encyclopedia of Genes and Genomes pathway enrichment results revealed that the signaling pathways mainly enriched were transcriptional misregulation in cancer, spliceosome, and the IL-17 signaling pathway. Our work identifies a six DNA methylated expression signature as a promising biomarker of chemo-resistance in GC, which provides new insights into the development of new strategies to overcome chemo-resistance in GC.
Journal • Epigenetic controller
|
IL17A (Interleukin 17A) • TFCP2 (Transcription Factor CP2) • BNIP5 (BCL2 Interacting Protein 5) • CCNL1 (Cyclin L1) • MCM2 (Minichromosome maintenance complex component 2)
over2years
Crystal structure of Bak bound to the BH3 domain of Bnip5, a noncanonical BH3 domain-containing protein. (PubMed, Proteins)
Structural analysis of the complex showed that Bnip5 interacts with Bak in a manner similar to that of the Bak-activating pro-apoptotic factor peroxisomal testis-enriched protein 1, particularly in the destabilization of the intramolecular electrostatic network of Bak. Our structure is considered to reflect the initial point of drastic and consecutive conformational and stoichiometric changes in Bak induced by Bnip5 BH3, which helps in explaining the effects of Bnip5 in regulating Bak-mediated apoptosis.
Journal
|
BCL2 (B-cell CLL/lymphoma 2) • BNIP5 (BCL2 Interacting Protein 5)